3.5 Point of Care Testing and Laboratory Procedures

Key Takeaways

  • CLIA-waived tests are simple laboratory tests that medical assistants can perform with minimal training, including glucose monitoring, urine dipstick, rapid strep, and pregnancy tests
  • Quality control (QC) must be performed according to manufacturer instructions, typically with each new lot number, new reagent, and at regular intervals
  • Urinalysis includes three components: physical (color, clarity, specific gravity), chemical (dipstick for pH, protein, glucose, blood, etc.), and microscopic (cells, casts, crystals)
  • Normal fasting blood glucose is 70-100 mg/dL; A1C below 5.7% is normal; results above these ranges may indicate prediabetes or diabetes
  • Specimen labeling must include patient name, date of birth, date and time of collection, collector's initials, and test ordered
  • Chain of custody procedures are required for drug screening specimens to ensure legal defensibility of results
Last updated: March 2026

Point of Care Testing and Laboratory Procedures

Point of care testing (POCT) refers to laboratory tests performed at or near the site of patient care, with results available quickly to guide clinical decisions. Medical assistants frequently perform CLIA-waived tests in physician offices and clinics.


CLIA Regulations

The Clinical Laboratory Improvement Amendments (CLIA) regulate all laboratory testing performed on human specimens:

CLIA CategoryComplexityWho Can PerformExamples
WaivedSimple, minimal risk of errorMedical assistants, trained staffGlucose meters, urine dipstick, rapid strep, pregnancy tests
Moderate complexityRequires more trainingMedical laboratory techniciansCBC (automated), basic chemistry panels
High complexityRequires specialized trainingMedical technologists, pathologistsFlow cytometry, genetic testing

CLIA-waived tests commonly performed by MAs:

  • Blood glucose monitoring (glucometer)
  • Urine dipstick analysis
  • Urine pregnancy test (hCG)
  • Rapid strep test (Group A Streptococcus)
  • Rapid influenza test
  • Fecal occult blood test (FOBT/iFOBT)
  • Hemoglobin A1C (certain devices)
  • Prothrombin time/INR (certain devices)
  • Rapid COVID-19 antigen test
  • Mononucleosis rapid test

Quality Control (QC)

Quality control ensures test results are accurate and reliable:

QC ComponentPurposeWhen
Control samplesKnown-value specimens tested to verify instrument accuracyEach new lot, new reagent, as per manufacturer schedule
CalibrationAdjusting the instrument to known standardsPer manufacturer instructions
Proficiency testingExternal evaluation of lab accuracyRequired for moderate/high complexity labs
Temperature logsMonitoring refrigerator/freezer temperatures for reagent storageDaily
Maintenance logsDocumenting instrument maintenance and calibrationPer schedule
QC logRecording all QC results, actions taken for out-of-range resultsWith each QC run

If QC is out of range:

  1. Do NOT report patient results
  2. Troubleshoot (check expiration, repeat with new control, recalibrate)
  3. Repeat QC
  4. Only report patient results when QC is within acceptable range
  5. Document all corrective actions

Urinalysis

Three Components of a Complete Urinalysis:

1. Physical Examination:

ParameterNormalAbnormal
ColorPale yellow to amberRed (blood), dark amber (dehydration), cloudy (infection)
ClarityClearCloudy/turbid (bacteria, WBCs, crystals)
Specific gravity1.005-1.030High (dehydration), low (overhydration, kidney issues)
OdorMild, slightly aromaticFoul (infection), fruity/sweet (ketones in diabetes)

2. Chemical Examination (Dipstick):

ParameterNormalClinical Significance of Abnormal
pH4.5-8.0 (avg 6.0)Alkaline: UTI; acidic: dehydration, diabetic ketoacidosis
ProteinNegativePositive: kidney disease, preeclampsia
GlucoseNegativePositive: diabetes, renal threshold exceeded
KetonesNegativePositive: diabetic ketoacidosis, starvation, low-carb diet
BloodNegativePositive: UTI, kidney stones, menstrual contamination
BilirubinNegativePositive: liver disease, bile duct obstruction
Urobilinogen0.2-1.0 mg/dLElevated: liver disease, hemolytic anemia
NitriteNegativePositive: bacterial UTI (gram-negative bacteria)
Leukocyte esteraseNegativePositive: WBCs present — possible UTI
Specific gravity1.005-1.030High/low: kidney function, hydration status

3. Microscopic Examination (performed by provider or qualified technician):

  • Red blood cells, white blood cells, epithelial cells
  • Bacteria, yeast
  • Casts (hyaline, granular, cellular)
  • Crystals (uric acid, calcium oxalate)

Blood Glucose Testing

Normal Values:

TestNormalPrediabetesDiabetes
Fasting blood glucose (FBG)70-100 mg/dL100-125 mg/dL≥126 mg/dL
Random blood glucose<140 mg/dL≥200 mg/dL (with symptoms)
Hemoglobin A1C<5.7%5.7-6.4%≥6.5%
Oral glucose tolerance test (OGTT)<140 mg/dL (2-hour)140-199 mg/dL≥200 mg/dL

Glucose Monitoring Procedure:

  1. Verify provider order and patient identity
  2. Perform hand hygiene; don gloves
  3. Select the puncture site (fingertip — lateral side is less painful)
  4. Cleanse with alcohol; allow to air dry completely (alcohol can affect results)
  5. Puncture with a lancet
  6. Wipe away the first drop of blood (contains tissue fluid that dilutes the sample)
  7. Apply the second drop to the test strip
  8. Record the result and report abnormal values to the provider

Hypoglycemia (<70 mg/dL): Symptoms include shakiness, sweating, confusion, irritability, rapid heartbeat Hyperglycemia (>200 mg/dL): Symptoms include excessive thirst, frequent urination, fatigue, blurred vision


Common Laboratory Tests and Normal Values

TestNormal RangeClinical Significance
WBC4,500-11,000/μLElevated: infection, inflammation; Low: immunosuppression
RBCM: 4.7-6.1; F: 4.2-5.4 million/μLLow: anemia; High: polycythemia
HemoglobinM: 14-18 g/dL; F: 12-16 g/dLLow: anemia
HematocritM: 42-52%; F: 37-47%Low: anemia; High: dehydration
Platelet count150,000-400,000/μLLow: bleeding risk; High: clotting risk
BUN7-20 mg/dLElevated: kidney dysfunction, dehydration
Creatinine0.7-1.3 mg/dLElevated: kidney dysfunction
Total cholesterol<200 mg/dLElevated: cardiovascular risk
LDL ("bad")<100 mg/dLElevated: cardiovascular risk
HDL ("good")>40 mg/dL (M); >50 mg/dL (F)Low: cardiovascular risk
Triglycerides<150 mg/dLElevated: cardiovascular risk
TSH0.4-4.0 mIU/LHigh: hypothyroidism; Low: hyperthyroidism
PT/INRPT: 11-13.5 sec; INR: 0.8-1.2Monitors warfarin therapy; INR goal typically 2.0-3.0

Specimen Collection and Handling

SpecimenCollection MethodSpecial Instructions
Clean-catch urineMidstream specimen after cleansingCleanse perineal area; catch midstream portion
24-hour urineAll urine collected over 24 hoursDiscard first void; collect all subsequent; keep refrigerated
Stool (FOBT)Small sample on test cardAvoid red meat, vitamin C, NSAIDs for 3 days before
Throat swabSwab tonsillar area and posterior pharynxAvoid touching tongue or cheeks; patient should not eat/drink 30 min prior
Wound cultureSwab from wound bedClean wound first; swab the active border, not the center
SputumCough specimen into sterile containerEarly morning, deep cough; rinse mouth first

Specimen Labeling Requirements: All specimens must be labeled with:

  • Patient's full name
  • Date of birth
  • Date and time of collection
  • Collector's initials
  • Test ordered
  • Source/site (if applicable)
Test Your Knowledge

Which of the following is a CLIA-waived test that a medical assistant can perform?

A
B
C
D
Test Your Knowledge

When performing a capillary blood glucose test, why should the medical assistant wipe away the FIRST drop of blood?

A
B
C
D
Test Your Knowledge

A positive result for nitrites AND leukocyte esterase on a urine dipstick most likely indicates:

A
B
C
D